TCM
CGON icon

TCG Crossover Management’s CG Oncology CGON Stock Holding History

TCG Crossover Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248M Hold
3,670,206
– – 7.11% 2
2025
Q4 		$152M Hold
3,670,206
– – 5.04% 3
2025
Q3 		$148M Hold
3,670,206
– – 7.27% 2
2025
Q2 		$95.4M Hold
3,670,206
– – 10.9% 1
2025
Q1 		$89.9M Hold
3,670,206
– – 12.26% 1
2024
Q4 		$105M Hold
3,670,206
– – 10.29% 1
2024
Q3 		$138M Hold
3,670,206
– – 11.73% 1
2024
Q2 		$116M Buy
3,670,206
+100,000
+3% +$3.47M 12.08% 1
2024
Q1 		$157M Buy
+3,570,206
New +$146M 12.39% 1

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return